Russia’s first potential Covid-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters.
Roche’s attempt to retool the company’s rheumatoid arthritis drug Actemra/RoActemra to treat patients hospitalized with severe Covid-19-related pneumonia failed in a late-stage trial.
Cambridge, Massachusetts-based Praxis Precision Medicines raised about $110 million in a Series C financing, led by Eventide Asset Management,
AstraZeneca reported successful results from the company’s Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end-stage kidney disease.
Moderna Inc. and Pfizer Inc. launched two 30,000-subject trials of Covid-19 vaccines that could clear the way for regulatory approval and widespread use by the end of 2020.
German biotech company BioNTech and U.S. drugmaker Pfizer said they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
Moderna launched an expanded Phase III clinical trial of the mRNA-1273 Covid-19 vaccine and the Biomedical Advanced Research and Development Authority (BARDA) added additional funding for the clinical program.
Moderna Inc. received an additional $472 million from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support development of the company’s novel coronavirus vaccine.
Three of the most advanced Covid-19 vaccines published data from early and mid-range clinical trials this week.
The U.S. Food and Drug Administration gave the green light to AstraZeneca for a new chronic obstructive pulmonary disease (COPD) treatment, Breztri Aerosphere.
